Vaccines

How pooled cell populations helped accelerate COVID-19 vaccine development – and what that means for the therapeutics of the future.

How will vaccine and therapeutic makers respond to the new SARS-CoV-2 variant?

Exploring the potential of vaccines for treatment equity.

The latest issue of The Bioprocess Curator included a lot of interesting news about vaccines. In case you missed it, here's some of the top stories.

Simple and efficient systems for continuous monitoring can make all the difference in developing innovative products.

Experts discuss how to tackle biopharma's need to move fast.

A University of Buffalo team has produced a reverse vaccination to help manage the symptoms of various chronic and autoimmune conditions.

Part 2 of our roundtable discussion with CDMOs covers outsourcing preferences, the demand for mRNA, and more.

The efforts of CDMOs have been absolutely crucial in the pandemic response. We ask five CDMO gurus how they reacted to COVID-19.

There’s a lot going on in the world of biopharma but never fear because we’ve got you covered…